Vivo Capital »

Monopar Therapeutics shares owned by Vivo Capital

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4M 91k 81.67

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Cidara Therapeutics Common (CDTX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Cogent Biosciences Common (COGT)
Sinovac Biotech SHS
Oric Pharmaceuticals Common (ORIC)
Geron Corp Common (GERN)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Bright Minds Biosciences Common (DRUG)
Tourmaline Bio Common (TRML)

View all positions for Vivo Capital

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics